Latest News

  • Review shows: EGb 761® optimizes standards of life for tinnitus patients!

    Read more
Umckaloabo®

Umckaloabo®

Umckaloabo® - EPs® 7630

for the treatment of acute bronchitis (inflammation of the bronchi)

Active ingredient:

Pelargonium sidoides root extract EPs® 7630

Schwabe Pharmaceuticals researched and developed an extract of Pelargonium sidoides into a clinically and pharmacologically well documented modern medicine for upper respiratory tract infections. Unlike other cough and cold remedies, the unique extract EPs® 7630 contained in the preparation Umckaloabo® not only relieves symptoms, but also shortens the duration of the illness itself, thus reducing the time of absence from school or work. It has a unique pharmacological profile which is ideal for the treatment of respiratory tract infections: It activates anti-viral defence, fights bacteria, and is mucolytic. Umckaloabo® is suitable for adults and children up from the age of 1 year and well tolerated.

Approved indication in Germany:

Acute bronchitis (inflammation of the bronchi)


Note: If conditions persist, are unclear or new, consult a doctor as diseases requiring medical clarification might be involved.


For information on precautions for use, side effects and contra-indications see the package leaflet or contact your doctor or pharmacist.


Data based on information issued 2008/05